- Home
- UFPT vs IRON Comparison
UFPT vs IRON Comparison
Compare UFPT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFPT
- IRON
- Stock Information
- Founded
- UFPT 1963
- IRON 2017
- Country
- UFPT United States
- IRON United States
- Employees
- UFPT N/A
- IRON N/A
- Industry
- UFPT Medical/Dental Instruments
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- UFPT Health Care
- IRON Health Care
- Exchange
- UFPT Nasdaq
- IRON Nasdaq
- Market Cap
- UFPT 1.9B
- IRON 2.1B
- IPO Year
- UFPT 1993
- IRON N/A
- Fundamental
- Price
- UFPT $241.92
- IRON $60.61
- Analyst Decision
- UFPT Buy
- IRON Strong Buy
- Analyst Count
- UFPT 2
- IRON 12
- Target Price
- UFPT $392.00
- IRON $92.08
- AVG Volume (30 Days)
- UFPT 94.1K
- IRON 380.3K
- Earning Date
- UFPT 08-05-2025
- IRON 08-07-2025
- Dividend Yield
- UFPT N/A
- IRON N/A
- EPS Growth
- UFPT 31.41
- IRON N/A
- EPS
- UFPT 8.15
- IRON N/A
- Revenue
- UFPT $547,560,000.00
- IRON N/A
- Revenue This Year
- UFPT $22.16
- IRON N/A
- Revenue Next Year
- UFPT $5.60
- IRON N/A
- P/E Ratio
- UFPT $28.98
- IRON N/A
- Revenue Growth
- UFPT 34.43
- IRON N/A
- 52 Week Low
- UFPT $178.26
- IRON $30.82
- 52 Week High
- UFPT $366.41
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- UFPT 52.78
- IRON 66.93
- Support Level
- UFPT $226.73
- IRON $57.42
- Resistance Level
- UFPT $244.75
- IRON $61.73
- Average True Range (ATR)
- UFPT 9.18
- IRON 2.32
- MACD
- UFPT -0.30
- IRON 0.26
- Stochastic Oscillator
- UFPT 50.49
- IRON 84.88
About UFPT UFP Technologies Inc.
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.